Paul Fornazzari resigned from Avicanna's board of directors, and is replaced by Michael Kott.
"I am excited for the opportunity to join the board of Avicanna Inc. and support the exciting next stages of the growth and evolution. I believe that Avicanna is in the centre of the evidenced based natural pharmaceuticals megatrend and has the potential to make a significant impact. Their strategy and vision were further validated by the recent communications from the White House on steps towards near term reclassification of cannabis in the US, which is one of many reasons why I am optimistic about the Company's future. Our investment thesis has been centered around investing in people and the founder's passion and entrepreneurial instinct and as a long-term shareholder I am confident in Avicanna's management team and share their vision," stated Michael Kott.
"I want to thank Paul for his significant contributions to board over the past 2 years. I look forward to his continued support as an advisor to the Company. I also want to welcome Michael to the board. Michael has been a great ally to the Company for many years, and we believe his broad expertise and related to capital markets will be positives for the Company, as we aim to continue to scale, expand, and unlock value for our shareholders," stated Aras Azadian, CEO of Avicanna Inc.
For more information:
Avicanna
[email protected]
www.avicanna.com
